Trials / Completed
CompletedNCT01815450
BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 369 (actual)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 12 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the safety and efficacy of BLI1100 formulations to placebo for the treatment of moderate to severe acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BLI1100 | BLI1100 topical cream |
| DRUG | BLI1100 - modified formulation | BLI1100 topical cream |
| DRUG | Placebo | Placebo topical cream |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-11-01
- First posted
- 2013-03-21
- Last updated
- 2015-02-02
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01815450. Inclusion in this directory is not an endorsement.